Investment: Antheia, Inc.

Antheia is taking a new approach to creating both existing and new medicines. Their technology involves reproducing active pharmaceutical ingredients through a yeast-based fermentation process.

"With this technology, you are not limited to reconstruct or copy what nature gives you. We take inspiration from nature's molecules, but improve upon them." — Christina Smolke, Co-Founder and CEO